Prevalence Of Ocular Surface Complications Related With A Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Published 2023 - 41st Congress of the ESCRS

Reference: PP26.11 | DOI: 10.82333/cche-s472